相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
Tyler N. Starr et al.
SCIENCE (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Daming Zhou et al.
CELL (2021)
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study
Michael Marks et al.
LANCET INFECTIOUS DISEASES (2021)
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier et al.
NATURE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie et al.
NATURE MEDICINE (2021)
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Neutralizing Activity of BNT162b2-Elicited Serum
Yang Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies et al.
SCIENCE (2021)
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
Alona Kuzmina et al.
CELL HOST & MICROBE (2021)
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
Nicholas G. Davies et al.
NATURE (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
Matan Levine-Tiefenbrun et al.
NATURE MEDICINE (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
Laith J. Abu-Raddad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Andrew Rambaut et al.
NATURE MICROBIOLOGY (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR
Kentaro Itokawa et al.
PLOS ONE (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Drivers of within-host genetic diversity in acute infections of viruses
Maoz Gelbart et al.
PLOS PATHOGENS (2020)
pTrimmer: An efficient tool to trim primers of multiplex deep sequencing data
Xiaolong Zhang et al.
BMC BIOINFORMATICS (2019)
MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform
K Katoh et al.
NUCLEIC ACIDS RESEARCH (2002)